Much anticipated Phase 3 data for Alzheimer’s drug lecanemab was presented at CTAD in 2022, showing the drug is as safe as the placebo…
Update 27 January, 2023: In January 2023, lecanemab was granted accelerated approval by the FDA and made available to patients under the brand name…
Most Alzheimer’s treatments on the market today help manage symptoms, like memory loss — but they don’t get at the root cause. Roche hoped their…
There were more than 140 experimental Alzheimer’s drugs in clinical trials as of the start of 2022. On the one hand, this number inspires…
Drugmaker Biogen had high hopes for its landmark Alzheimer’s medication Aduhelm. But ever since its controversial July 2021 approval by the Food and Drug…
Vaccines are considered one of the greatest innovations in medical history. Immunizations help train the body’s immune system to recognize and respond to a…
Biogen has abandoned its application for the approval of anti-amyloid Alzheimer’s therapy Aduhelm (aducanumab) with European regulatory agencies. This marks yet another setback arises…
I’m a 52-year-old pediatrician diagnosed with younger-onset Alzheimer’s disease in November 2020. Alzheimer’s is not my story, but now it’s my life. This is what…
The lack of effective treatments for Alzheimer’s have spurred scientists to rethink the dominant approach to tackling the disease: the amyloid hypothesis. This hypothesis…
“It’s been very confusing,” said Pam Montana, an advocate for Alzheimer’s who has participated in several clinical trials herself, adding that the recent memo…
Last week, the Centers for Medicare and Medicaid Services (CMS) released a proposal limiting Medicare coverage of the anti-amyloid drug Aduhelm to only participants…
Download this explainer as a PDF. The Alzheimer’s Association: Helped assemble a 2018 consortium that led to a biomarker-based definition of Alzheimer’s, controversial because…
Scientists have their eyes set on spotting Alzheimer’s early. The earlier the disease can be diagnosed, the better the chance that a combination of…
Alzheimer’s is a notoriously difficult disease to identify with certainty. By the time a patient receives a diagnosis, its pathology in the brain is…
What’s the difference between treating Alzheimer’s symptoms and modifying the disease? Despite decades of research, the underlying cause of Alzheimer’s continues to evade scientists….